AAPG · Ascentage Pharma Group International · Debt
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Borrowings | 2025-12-31 | CNY 1,979,719,000 | 20-F filed 2026-04-29 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Borrowings | 2025-12-31 | USD 283,096,000 | 20-F filed 2026-04-29 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Lease liabilities | 2025-12-31 | CNY 22,196,000 | 20-F filed 2026-04-29 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Lease liabilities | 2025-12-31 | USD 3,174,000 | 20-F filed 2026-04-29 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Other current borrowings | 2025-12-31 | CNY 1,968,000 | 20-F filed 2026-04-29 |
| Other current borrowings | 2025-12-31 | USD 281,000 | 20-F filed 2026-04-29 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.